The Complainant said the claims were misleading as The overall scientific literature doesn t show that Arnica helps the body.

Size: px
Start display at page:

Download "The Complainant said the claims were misleading as The overall scientific literature doesn t show that Arnica helps the body."

Transcription

1 COMPLAINT NUMBER COMPLAINANT ADVERTISER ADVERTISEMENT D. Ryan Pharmacy Direct Pharmacy Direct Website DATE OF MEETING 11 October 2016 OUTCOME Not Upheld in part / Settled in part SUMMARY The website advertisements on Pharmacy Direct ( were for a range of different Arnica products. The products included Artemis Tissue Repair Sports Cream, Skybright Arnica Liniment Spray, Naturo Pharm Arnica Plus Cream, Naturo Pharm Arnica Extra Strength Gel, Naturo Pharm Arnica Cream and Naturo Pharm Arnica Lotion. These products made claims about the effectiveness of Arnica. The Complainant said the claims were misleading as The overall scientific literature doesn t show that Arnica helps the body. The Complaints Board noted that the Advertisers and the Media had amended the wording on the website so that the claims relating to the benefits of the various products were now low level claims that had been supported. The Complaint Board ruled the Complaint was Not Upheld in part and Settled in part. [No further action required] Please note this headnote does not form part of the Decision. COMPLAINTS BOARD DECISION The Chair directed the Complaints Board to consider the advertisements with reference to the Therapeutic Products Advertising Code, Principles 2, 3 and Part B1 Requirements 3,4 and 4(a). The Complaints Board ruled the complaint was Not Upheld in part and Settled in part. The advertisements subject to complaint were on the Pharmacy Direct website. In their response, Pharmacy Direct said Manufacturer product information is sourced from product packaging, product fact sheets, and the manufacturers website if they have one. Pharmacy Direct also said As a result of this complaint we reviewed the products quoted and have found that some changes in these products had not been notified to us so we will be addressing that issue with these manufacturers directly to remind them of the process they are meant to be following. However we have refreshed the content of all of these products to reflect the current content as can be found on the manufacturers websites and I would hope this addresses the issues raised.

2 The advertisements subject to complaint were different companies and related to different products. The Complaints Board dealt with each individual product separately. Skybright Arnica Liniment Spray The Advertisement for Skybright Arnica Liniment Spray said in part Arnica has been researched extensively and is well known for its healing properties. High potency natural calming & healing cream Aids healing & mobility and Soothes muscles and tired joints and helps with general muscle function. It also can be beneficial for people who are bedridden or disabled, when applied as a soothing muscle rub. The Complainant said this advertisement was misleading as The overall scientific literature doesn t show that Arnica helps the body. The Advertiser, Skybright, had reviewed its advertisement and changed the wording to read Specially formulated to assist the body s natural healing ability before and after exercise. Soothes muscles and tired joints and helps with general muscle function. The Complaints Board considered both the original and changed wording. The Complaints Board agreed that the original wording in the advertisement made very low level claims of support and said the research available supported the use of Arnica for the purpose advertised. Therefore the Complaints Board ruled the complaint in relation to Skybright Arnica Liniment Spray was Not Upheld. Artemis Tissue Repair Sports Cream The advertisement for Artemis Tissue Repair said assisting the body's natural response to shock, injury, fatigue and bruising aids normal muscle recovery after strenuous exercise or exertion. Aids normal defence mechanisms in times of trauma and after surgery. Commonly used to help the body respond to trauma injuries and shock. Great for bruising, sprains, swelling and other superficial muscle and tissue injuries. Also good for joint mobility and suppleness. The Complainant said the claims in the advertisement could not be substantiated. In its response, the Advertiser, Artemis said in part: As an active herbal product, Arnica is a much researched herb. It has a wellestablished empirical evidence base in the treatment of trauma injuries (e.g. bruises, sprains and fractures) and rheumatic conditions that produce muscular pain and joint stiffness. Arnica is endorsed for the treatment of these conditions by many international regulatory bodies and herbal authorities including the European Medicines Agency, the World Health Organisation, Health Canada, the German Commission E and the European Scientific Co-operation on Phytotherapy. The Complaints Board was advised the wording in the advertisement for this product had been changed and now states: This powerful sports cream combines traditional plant medicine to support quick recovery for muscles. Tissue Repair Cream is effective in repairing and rebuilding tissue. Effective for post surgery, bruising, sports injuries or everyday sprains and strains. For deep-seated strains, use Strain Repair Cream - the same powerful formula but with the added benefit of warming Cayenne. Combine with Tissue and Strain Repair Oral Liquid to support healing from within. Recover quickly with Tissue Repair Cream. 2

3 Artemis also provided information in support of its advertising about the use of arnica and noted its use of the pre-vetting service for the wording in its product listings. The Complaints Board reviewed the original advertisement and the amended version and agreed the amended advertisement made lower level claims in line with the evidence provided about the use of arnica. Taking into account the action taken by the Advertiser to comply with the Therapeutic Products Advertising Code, the Complaints Board ruled the complaint about the Artemis Tissue Repair Sports Cream be Settled. Naturo Pharm Naturo Pharm had four products advertised on the Pharmacy Direct website. Naturo Pharm Classical Arnica Cream Naturo Pharm Classical Arnica Extra Strength Gel Naturo Pharm Classical Arnica Plus Cream Naturo Pharm Classical Arnica Lotion The wording in the advertisements included Assisting the body s natural response to shock, injury, fatigue and bruising. Aids normal muscle recovery after strenuous exercise or exertion Aids normal defence mechanisms in times of trauma and after surgery. Commonly used to help the body respond to the trauma injuries and shock Great for bruising, sprains, swelling and other superficial muscle and tissue injuries. Also good for joint mobility and suppleness. The Complainant said the advertisements for the Naturo Pharm products made strong therapeutic claims and needed to be substantiated. In response, the Advertiser, Naturo Pharm advised that the wording for its products on the Pharmacy Direct website included additional information that was not sourced from it. Naturo Pharm confirmed the wording on the Pharmacy Direct website for the products subject to complaint had been revised to match the wording from its own pre-vetted website. The new wording included: Arnica plus Cream is a Naturo Pharm Classical plus product that assists rapid response to bruising, fatigue, injury, shock and trauma and aids natural muscle recovery after strenuous exercise or exertion. Arnica plus is also available in a convenient oral spray form. Arnica Extra Strength Gel assists normal muscle recovery after strenuous exercise or injury. Its special gel base allows it to penetrate quickly into the skin giving maximum absorption of the higher strength Arnica tincture Arnica Lotion assists the body s natural response to shock, injury, fatigue and bruising and aids normal muscle recovery after strenuous exercise or exertion. Diluted with water, it is ideal to be used as a wet compress that can be left on overnight under a loose elastic bandage. 3

4 Arnica Cream is a Naturo Pharm product that assists rapid response to bruising, fatigue, injury, shock and trauma and aids natural muscle recovery after strenuous exercise or exertion. Arnica plus is also available in a convenient oral spray form. Naturo Pharm also provided information in support of its advertising about the use of arnica and noted its use of the pre-vetting service for its own website. The Complaints Board agreed the action taken by the Advertiser to amend the wording for the four products in front of it meant that the complaint in relation to this advertising was Settled. In the course of considering the complaints about each of the products the Complaints Board discussed the information provided by the advertisers in relation to the claims made about the products under the Therapeutic Products Advertising Code. The Complaints Board acknowledged there were different views about the efficacy of arnica. However, in the context of the low level claims made in the advertising before it, and taking into account the changes made, the Complaints Board agreed it was sufficient to rule that the complaint was Not Uphold in part and Settled in part. DESCRIPTION OF ADVERTISEMENT The website advertisements on Pharmacy Direct ( are for a range of different Arnica products. The products are Artemis Tissue Repair Sports Cream, Skybright Arnica Liniment Spray, Naturo Pharm Arnica Plus Cream, Naturo Pharm Arnica Extra Strength Gel, Naturo Pharm Arnica Cream and Naturo Pharm Arnica Lotion. All of these products are making claims around the effectiveness of Arnica. COMPLAINT FROM D. RYAN Pharmacy Direct breaks the Therapeutic Products Advertising Code Part B1 Requirement 3 for several of its Arnica products. The code states that advertisements must contain true and balanced claims. I'll list 4 products, but there are plenty of other products that have similar claims. The therapeutic claims being made are: Arnica (Arnica montana flos): Most effective first aid herb for impact injuries causing bruising, sprains, swelling, fractures and muscular and joint pain. Arnica is excellent after surgery to relieve trauma, swelling and pain. It stimulates circulation to the injured area and re-absorbs internal bleeding which accelerates healing. assisting the body's natural response to shock, injury, fatigue and bruising aids normal muscle recovery after strenuous exercise or exertion. Aids normal defence mechanisms in times of trauma and after surgery. Commonly used to help the body respond to trauma injuries and shock. Great for bruising, sprains, swelling and other superficial muscle and tissue injuries. Also good for joint mobility and suppleness

5 Sprain Away is a premium potency combination of NZ-grown Arnica and Comfrey. There is a wealth of evidence supporting the calming and healing action of these two herbs, and in combination, they provide proven natural support for strained muscles, sprains, stiff joints, bruises and sports injuries. Arnica has been researched extensively and is well known for its healing properties. High potency natural calming & healing cream Aids healing & mobility Soothes muscles and tired joints and helps with general muscle function. It also can be beneficial for people who are bedridden or disabled, when applied as a soothing muscle rub. The overall scientific literature doesn t show that Arnica helps the body. The review Systematic Review on the Efficacy of Topical Arnica montana for the Treatment of Pain, Swelling and Bruises concluded: The efficacy of Arnica in doses of 10% and below is not supported by the available evidence. More research is needed to determine if higher doses would be effective and remain safe. The review Efficacy of homeopathic arnica: a systematic review of placebo-controlled clinical trials concluded: The claim that homeopathic arnica is efficacious beyond a placebo effect is not supported by rigorous clinical trials. There is some evidence that it actually makes things worse. A paper concluded "Rather than decreasing leg pain, arnica was found to increase leg pain 24 hours after eccentric calf exercises. This effect did not extend to the 48-hour measurement." THERAPEUTIC PRODUCTS ADVERTISING CODE Principle 2 - Advertisements must be truthful, balanced and not misleading. Claims must be valid and have been substantiated. Principle 3 - Advertisements must observe a high standard of social responsibility. Part B1 Requirement 3 To assist consumers to make informed decisions, advertisements must contain truthful and balanced representations and claims that are valid and have been substantiated Part B1 Requirement 4 Advertisements must not directly nor by implication, omission, ambiguity, exaggerated claim or comparison: a) mislead or deceive, or be likely to mislead or deceive; RESPONSE FROM MEDIA, PHARMACY DIRECT Thank you for your recent letter dated 4th May 2016 advising us of a consumer complaint about a number of arnica products listed on our website from Nature Pharm, Skybright, and Artemis. 5

6 Before I comment on the specific matter of the complaint I wish to clarify how product text is approved for placement on the Pharmacy Direct website: As NZ's leading online Pharmacy we take our responsibility to provide accurate information to the consumer extremely seriously, especially to those shopping independently online, so that they can make an informed and safe choice. The core principle of "First, do no harm" is paramount in the provision of all our services. As such we operate to a very strict set of Standard Operating Procedures and templates for placing products on the site. This template covers information on the potential benefits but also specific information on ingredients, dosage, and risks. ALL material for a product is provided to us directly by the manufacturer or supplier and in the main it is normally TAPS approved prior to being supplied. Note that we do not, under any circumstance, add or embellish in any way the supplied material. We do review and we may remove content we consider not appropriate but overall we do not create any product content ourselves. Manufacturer product information is sourced from product packaging, product fact sheets, and the manufacturers website if they have one. We also operate the business on the mantra "Good health is a right, not a privilege" and we aim to achieve this through giving the consumer choice (Availability) and by making healthcare products as affordable as we can (Affordability). So we hold ourselves accountable to a very high standard at all times, without compromise, and we would never knowingly or intentionally allow content on the site that could mislead consumers, In regards the complaint relating to the arnica products, these have been listed on our site for quite some time using material sourced from the manufacturers as stated above. This content is widely used on websites and by high street stores that will be selling these products. With the current activity around the Natural Health and Supplementary Products Bill (342-2) manufacturers are reviewing all their product collateral and as part of that process they work with us to ensure their products are accurately represented on our site. As a result of this complaint we reviewed the products quoted and have found that some changes in these products had not been notified to us so we will be addressing that issue with these manufacturers directly to remind them of the process they are meant to be following. However we have refreshed the content of all of these products to reflect the current content as can be found on the manufacturers websites and I would hope this addresses the issues raised. I would also note that the complainant's issue appears to be the general availability of arnica as an ingredient in NZ due to their favoured opinion and that is an entirely different matter altogether that cannot inhibit any retailer from legitimately representing and selling the product in a proper manner. So whilst we appreciate this information required updating we would have to refute the complaint that the products in any way make any inappropriate or unsafe efficacy claims or fail to comply with the TPAC core principles 1 to 3. There is a reasonable pool of studies on arnica, some of which are supportive whilst others are unsupportive or inconclusive, and that is where it is vital the consumer can make an informed and safe choice, especially buying online. I hope the ASA can recognise that we take all measures to protect the consumer from any inappropriate content and that we take all consumer concerns as serious and endeavour to respond accordingly and take prompt remedial action when deemed necessary. We believe the revised text should deal to the complaint concerns and would welcome the ASA feedback on the revisions. 6

7 We look forward to hearing from you in due course RESPONSE FROM ADVERTISER, SKYBRIGHT NATURAL HEALTH This letter is in response to complaint Re: Pharmacy Direct Digital Marketing Complaint I would like to take this opportunity to let you know that Skybright is treating this matter with the upmost importance and will assist ASA throughout this process. We acknowledge the fact the complainant has addressed Pharmacy Direct as the primary Advertiser in this instance, however further to our commitment and while you are conducting this investigation, we believe its best practice to respect all parties related in the complaint so I have removed all related Arnica Liniment images, content and related pages from website: Background: I became Managing Director in April this year, to date my primary focus has been on around our brand identity, which includes but not limited to content, process and structure. This being said I would like to point out that we are currently reviewing all print and web content and have engaged the services of a TAPS adjudicator to assist us in this process. I can confirm that Skybright s Arnica Liniment content has been reviewed in the past via the required pre-vetting process please refer to # PP6055 & PP7598 also to assist you with your investigation I have included the full list of ingrediants (listed below) to enable you to make an informed decision. Skybright Arnica Liniment contains: Arnica Witch Hazel Rosemary Lavender Alcohol Summary: We have acted professionally and in the interest of all parties. The removal of this product from our web platform shows our commitment and cooperation to date. 7

8 We pride ourselves on quality, transparency and industry experience and are proud of our position in the Natural Health industry. Thank you for your time so far, please don t hesitant in contacting me if you require any further information. RESPONSE FROM ADVERTISER, ARTEMIS Thank you for the opportunity to respond to the complaint by Mr. Daniel Ryan / The Society for Science Based Healthcare. Mr. Ryan refers to the therapeutic claims being made about our use of Arnica (Arnica montana flos.). He is specifically concerned about the following text: Arnica (Arnica montana flos): is the most effective first aid plant for impact injuries causing bruising, sprains, fractures and muscular and joint stiffness. Arnica is excellent after surgery to relieve trauma and support healing. It supports circulation to the injured area and accelerates healing. The wording in this product listing is taken directly from our website and has been approved for use by TAPS Adjudicator Peter Pratt. The TAPS approval number is PP7926. In response to Mr Ryan s claims, we would firstly like to clarify that we do not use homeopathic preparations of herbs in our products. Mr. Ryan s research evidence makes specific reference to the ineffectiveness of homeopathic products, which ours is not. As an active herbal product, Arnica is a much researched herb. It has a well-established empirical evidence base in the treatment of trauma injuries (e.g. bruises, sprains and fractures) and rheumatic conditions that produce muscular pain and joint stiffness. Arnica is endorsed for the treatment of these conditions by many international regulatory bodies and herbal authorities including the European Medicines Agency, the World Health Organisation, Health Canada, the German Commission E and the European Scientific Cooperation on Phytotherapy. In the construction of their respective monographs and approval for use as an ingredient, these regulatory bodies evaluate a broad array of empirical and clinical evidence to substantiate pharmacological action and efficacy. We have attached these monographs as summaries of the considered evidence in support of Arnica s therapeutic benefits and our product claims. We hope this information helps to address Mr Ryan s concerns. If further information is required, we can provide further copies of individual research papers and trials that speak to the efficacy of this herb. We look forward to hearing the outcome of your decision. Attached: TAPS approval PP7926 American Botanical Council (2000). Arnica Flower. Excerpt from Herbal Medicine: Expanded Commission E Monographs Arnica. Austin, Texas, USA. American Botanical Council / Integrative Medicine Communications. 8

9 ESCOP (2003). Arnicae flos (Arnica Flower). ESCOP Monographs, Second edition. Exeter, UK: European Scientific Cooperative on Phytotherapy / Thieme. European Medicines Agency. (2014). European Union herbal monograph on Arnica montana L., flos. Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/198793/2012. European Medicines Agency. (2014). List of references supporting the assessment of Arnica montana L., flos Final. Committee on Herbal Medicinal Products (HMPC). EMA/HMPC/198792/2012 Health Canada. (2011). Arnica monograph. Natural Health Products Ingredients Database. Retrieved from World Health Organization (2007). Flos Arnicae. WHO Monographs on selected medicinal plants, Volume 3. Geneva, Switzerland: World Health Organization. RESPONSE FROM ADVERTISER, NATUROPHARM LTD A basic, neutral description of the advertisement Date advertisement began Where the advertisement appeared (all locations e.g. TV, Billboard, Newspaper Website Is the advertisement still accessible where and until when? A copy of digital media file(s) of the advertisement if the complaint relates to on-screen graphic, please send a broadcast quality version. Who is the product / brand target audience? Please provide a copy of the media schedule. Pre-vetting Approval number if applicable Four different products for topical application containing herbal Arnica that were included for sale on the Pharmacy Direct website. The product descriptions included information pertaining to typical product use. Some of this information was taken from the Naturo Pharm website, but not all of it. Unfortunately we do not know when the products first appeared on the Pharmacy Direct website. Website: the adverts in question were on the Pharmacy Direct website, with some of the wording having been taken from the Naturo Pharm website As discussed in full in the response document that follows, the product advertisements that appeared on the Pharmacy Direct website that the complaint pertains to have been updated since the complaint was made. The wording that now appears on the Pharmacy Direct website is an exact match for the Naturo Pharm website. See attached folders: Appendix 1 Naturo Pharm web pages Appendix 2 Pharmacy Direct web pages Consumers with an interest in natural healthcare options TAPS Approval No: PP7069 (This is the Approval no. for the Naturo Pharm website) 9

10 Clear substantiation on claims that are challenged by the complainant. Please see the Guidance Note. Please see the response document that follows for a full discussion. Naturo Pharm s Response: Having recently received your letter bringing the issue of complaint to our attention, we were concerned to hear that a complaint had been made against Naturo Pharm products. We take our responsibility regarding responsible advertising seriously and in keeping with this, all advertising material released into the public arena has undergone the TAPS approval process, in an attempt to ensure that we are not in breach of the advertising requirements as they pertain to therapeutic advertising of natural health products. We are taking this matter seriously and trust our response addresses this matter appropriately. While the complaint in question was raised against products as they appeared on the Pharmacy Direct website, this response is not being made on behalf of any other party. As a starting point we would first like to clarify that, while the bulk of the advertisement wording in question was extracted from Naturo Pharm s website (see Appendix 1 Naturo Pharm web pages), there was additional wording included on the website that did not come from Naturo Pharm. Having contacted Pharmacy Direct to discuss the matter of the additional wording, we further discovered that they have recently updated their website and the amended wording is now an exact match to that on our own website (see Appendix 2 Pharmacy Direct web pages). Of the quoted wording in question, the following is from Naturo Pharm s website: Arnica Cream assists the body s natural response to shock, injury, fatigue and bruising and aids normal muscle recovery after strenuous exercise or exertion. Aids normal defence mechanisms in times of trauma and after surgery The following is additional and does contain wording that we understand could represent a therapeutic claim and as such is not in keeping with Naturo Pharm s process of releasing advertising material to consumers: Commonly used to help the body respond to trauma, injuries and shock. Great for bruising, sprains, swelling and other superficial muscle and tissue injuries. We have included bold formatting for the words we believe would be of greatest concern in representing a therapeutic claim, and which are not words that have been extracted from any Naturo Pharm published advertisements. It is, likewise, the additional wording quoted immediately above that has already been removed from Pharmacy Direct s website. Naturo Pharm products, like most complementary healthcare products, are not registered medicines and as such we recognise that we are not able to make therapeutic claims about our products. We make every effort to comply both with the Medicines Act 1981 and the Advertising Codes of Practice. We do not believe that we have made any therapeutic claim in respect of any of our products. All of the material that we make available to consumers is submitted to the Therapeutic Advertising Pre-vetting Service ( TAPS ) for approval prior to its publication and is published with the relevant TAPS reference stated on it. Addressing the complaint: According to the complaint the complainant has complained about the claims Pharmacy 10

11 Direct has made on its website with respect of a number of Arnica products, some of which would be supplied by Naturo Pharm. The complainant suggests that in respect of our products, therapeutic claims have been made that are not true and balanced, thereby contravening the Advertising Code Part B1 Requirement 3. We do not believe that we have represented the products as the complainant alleges. As already mentioned, Naturo Pharm seeks and obtains TAPS approval for material made available to consumers. In this instance the issue is somewhat muddied by the fact that the Pharmacy Direct website did include wording that we understand could represent a therapeutic claim. However, as discussed previously, this wording was not extracted from Naturo Pharm marketing materials and has, further, been removed from their website. The wording that appeared on the Pharmacy Direct website which does seem to have been extracted from Naturo Pham s website, is wording that was TAPS approved, since we have obtained TAPS approval for the whole of the Naturo Pharm website (TAPS Approval No: PP7069). The words used in describing our Arnica products are assists the body s natural response or aids normal. Our understanding is that the use of this type of wording is acceptable and is effectively as far as one can go without making a therapeutic claim. The complainant states that the overall scientific literature doesn t show that Arnica is helpful to the body. While we recognise that there is scientific research that concludes that Arnica is not helpful, there are likewise research studies that show positive outcomes for the use of herbal Arnica. We believe that it is beyond the scope of this complaint to conduct a full literature review on the efficacy of herbal Arnica, considering that while it is required to substantiate direct claims made with scientific evidence, we don t believe that we have made any direct therapeutic claims. If further information in this regard is required in order to settle this complaint then please do not hesitate to contact us. Addressing the relevant parts of the Advertising Codes of Practice: As already stated Naturo Pharm tries to comply with provisions of the Code and we believe that this is the case in respect of both the B1 Requirements 3, 4, 4a; and Principles 2 and 3 to which you have referred us. Monographs published in phytotherapy texts support the use of Arnica in the manner that it has been described in the products under question. We have attached some copies of phytotherapy text references as an example (Appendix 3 Phytotherapy texts), bearing in mind that these are a very small sample and many further examples are available. Considering our use of TAPS approved wording, in which we don t believe that we have made any therapeutic claims, as well as our description of Arnica being in keeping with those suggested by phytotherapy texts; we feel that we have met the principles of having advertisements that present a truthful and balanced representation, and that we have not made any therapeutic claims. For the same reasons we don t believe that we have made any exaggerations in respect of our advertisements, nor have we misled or deceived. By demonstrating a long history (over 30 years) in the industry in which we have made every effort to comply with all regulations, including those of the Advertising Codes of Practice, we feel that Naturo Pharm meets a high standard of social responsibility in respect to advertising our products. 11

12 We have a history of good working relationships with regulatory authorities and wish to maintain these relationships going forward. We believe that the manner in which we have dealt with the complaint demonstrates our commitment to maintaining these relationships and complying with the current regulatory environment. We trust that the information provided is of assistance in your consideration of the complaint that has been made. If we can be of any further assistance please do not hesitate to contact us. We look forward to hearing the outcome of your consideration of these matters. 12

The Complainant said there was no evidence to support the therapeutic claims made by Bioptron.

The Complainant said there was no evidence to support the therapeutic claims made by Bioptron. COMPLAINT NUMBER 15/463 COMPLAINANT ADVERTISER ADVERTISEMENT D. Ryan Balanced Energy Balanced Energy Website DATE OF MEETING 26 January 2016 OUTCOME Upheld SUMMARY The website advertisement by Balanced

More information

Pharmacare Laboratories Pty Ltd. Code sections 4(1)(b), 4(2)(a), 4(2)(c), 4(2)(d), 4(4), 5(2) Withdrawal of advertisements

Pharmacare Laboratories Pty Ltd. Code sections 4(1)(b), 4(2)(a), 4(2)(c), 4(2)(d), 4(4), 5(2) Withdrawal of advertisements COMPLAINTS RESOLUTION PANEL DETERMINATION Complaint 2016-10-023 Horny Goat Weed for Him ARTG ID: AUST L 134979 Meeting held 19 January 2017 Complaint summary^ Complainant Advertisers Requested anonymity

More information

Information about cases being considered by the Case Examiners

Information about cases being considered by the Case Examiners Information about cases being considered by the Case Examiners 13 October 2016 1 Contents Purpose... 3 What should I do next?... 3 Background... 4 Criteria that Case Examiners will consider... 5 Closing

More information

1. We refer to your request made under the Official Information Act 1982 of 29 August 2018 for the following information:

1. We refer to your request made under the Official Information Act 1982 of 29 August 2018 for the following information: 26 September 2018 Official Information Act #18.046 Homeopathic Products 1. We refer to your request made under the Official of 29 August 2018 for the following information: 1.1. The number of complaints

More information

Therapeutic Advertising Pre-Vetting System (TAPS)

Therapeutic Advertising Pre-Vetting System (TAPS) Therapeutic Advertising Pre-Vetting System (TAPS) Don t be Complacent Direct to Consumer Advertising is always under the microscope. It is never off the Radar of opponents. The Medicines Act revision is

More information

COMPLAINT NUMBER 17/008 COMPLAINANT. J Fuller ADVERTISER. Dr Ronald Goedeke, hcg Team ADVERTISEMENT. Diethcg.co.nz Website

COMPLAINT NUMBER 17/008 COMPLAINANT. J Fuller ADVERTISER. Dr Ronald Goedeke, hcg Team ADVERTISEMENT. Diethcg.co.nz Website COMPLAINT NUMBER COMPLAINANT ADVERTISER ADVERTISEMENT J Fuller Dr Ronald Goedeke, hcg Team Diethcg.co.nz Website DATE OF MEETING 14 March 2017 OUTCOME Upheld SUMMARY The website advertisement for The hcg

More information

Code sections 4(1)(b), 4(2)(a), 4(2)(c), 4(2)(e)(ii) Withdrawal of advertisement. Withdrawal of representations

Code sections 4(1)(b), 4(2)(a), 4(2)(c), 4(2)(e)(ii) Withdrawal of advertisement. Withdrawal of representations COMPLAINTS RESOLUTION PANEL DETERMINATION Complaint 2016-09-025 Fertility Formula Male ARTG ID: AUST L 205447 Meeting held 17 November 2016 Complaint summary^ Complainant Advertiser Subject matter of complaint

More information

Guideline on the Regulation of Therapeutic Products in New Zealand

Guideline on the Regulation of Therapeutic Products in New Zealand Guideline on the Regulation of Therapeutic Products in New Zealand Part 10: Requirements for information for prescribers and consumers Edition 7.0 January 2016 Section 1: Legislation Section summary This

More information

Good Practice Notes on School Admission Appeals

Good Practice Notes on School Admission Appeals Good Practice Notes on School Admission Appeals These notes are for supplementary information only and have no statutory basis. Full guidance is available from the Department for Education www.dfe.gov.uk

More information

Code sections 4(1)(b), 4(2)(a), 4(2)(c) No sanction undertakings accepted

Code sections 4(1)(b), 4(2)(a), 4(2)(c) No sanction undertakings accepted COMPLAINTS RESOLUTION PANEL DETERMINATION Complaint 2016-10-014 Blackmores Bilberry Eyestrain Relief ARTG ID: AUST L 153217 Meeting held 15 December 2016 Complaint summary^ Complainant Advertiser Subject

More information

The Nutrition (Amendment) (EU Exit) Regulations 2018

The Nutrition (Amendment) (EU Exit) Regulations 2018 The Nutrition (Amendment) (EU Exit) Regulations 2018 A public consultation Contents Introduction... 3 Why we are consulting... 4 Nutrition and Health Claims... 6 Proposals... 6 Vitamins, minerals, and

More information

Guideline for Advertising of e-cigarettes

Guideline for Advertising of e-cigarettes GUIDELINE 43 Guideline for Advertising of e-cigarettes Last Updated May 2015 What kind of product is this guideline for? What is the purpose of this guideline? Electronic, or e-cigarettes, are battery

More information

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH

MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH 11 MEDICINES, MEDICAL DEVICES, TREATMENTS AND HEALTH Background The rules in this section are designed to ensure that advertisements that include health claims (please see Section 13 for health claims

More information

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs)

Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs) Complementary Medicines Australia submission to the Therapeutic Goods Administration Consultation: Consultation: Discontinuing pre-market evaluation of Herbal Component Names (HCNs) 12 January 2018 To:

More information

MARKETING STANDARDS FOR MEMBERSHIP

MARKETING STANDARDS FOR MEMBERSHIP MARKETING STANDARDS FOR MEMBERSHIP The Vapor Technology Association (VTA) is a leading national trade association in the electronic cigarette and vapor product industry. VTA represents the manufacturers,

More information

Consumers Association s response to the European Commission s Discussion paper on nutrition claims and functional claims

Consumers Association s response to the European Commission s Discussion paper on nutrition claims and functional claims Introduction Consumers Association s response to the European Commission s Discussion paper on nutrition claims and functional claims Consumers Association (CA), publisher of Which?, Health Which? and

More information

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES

Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES Issue: March 2016 PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES PROFESSIONAL STANDARDS AND GUIDANCE FOR ADVERTISING MEDICINES AND PROFESSIONAL SERVICES CONTENTS

More information

Developments in regulations for complementary medicines (including traditional medicines and other natural health products)

Developments in regulations for complementary medicines (including traditional medicines and other natural health products) Developments in regulations for complementary medicines (including traditional medicines and other natural health products) A/Professor Jo Barnes BPharm (Hons) PhD RegPharmNZ MPSNZ FLS School of Pharmacy,

More information

Case Report ISSUES RAISED Food and Beverage Code unscientific nutrition claims DESCRIPTION OF THE ADVERTISEMENT

Case Report ISSUES RAISED Food and Beverage Code unscientific nutrition claims DESCRIPTION OF THE ADVERTISEMENT Case Report 1 Case Number 0201/10 2 Advertiser Well Naturally 3 Product Health Products 4 Type of Advertisement / media Internet 5 Date of Determination 26/05/2010 6 DETERMINATION Dismissed ISSUES RAISED

More information

Healer at Home Natural First Aid for Trauma and Injuries. Healer at Home. Natural First Aid for Trauma and Injuries

Healer at Home Natural First Aid for Trauma and Injuries. Healer at Home. Natural First Aid for Trauma and Injuries Healer at Home Natural First Aid for Trauma and Injuries Healer at Home Natural First Aid for Trauma and Injuries Ryan Carnahan, RMT, DCH www.ryancarnahan.com Healer at Home Natural First Aid for Trauma

More information

This paper contains analysis of the results of these processes and sets out the programme of future development.

This paper contains analysis of the results of these processes and sets out the programme of future development. Fitness to Practise Committee, 14 February 2013 HCPC witness support programme Executive summary and recommendations Introduction This paper outlines the approach taken by HCPC in relation to witness management

More information

TGA: the current regulatory reform agenda

TGA: the current regulatory reform agenda TGA: the current regulatory reform agenda ASMI 2012 Conference: 13 November 2012 Future proofing the consumer healthcare industry Dr John Skerritt, National Manager The Therapeutic Goods Administration

More information

GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS

GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS The purpose of this guidance document The purpose of this guidance is to explain what happens if you are asked by the General Optical

More information

DE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES

DE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES DE-DESIGNATION OF YELLOW FEVER VACCINATION CENTRES January 2014 INDEX Page 1. Introduction 3 2. De-designating a YFVC 4 3. The de-designation process 5-6 4. Repeated breaches of the standards for designation

More information

PRIMARY CARE MEDICAL DIRECTOR v PFIZER

PRIMARY CARE MEDICAL DIRECTOR v PFIZER CASE AUTH/2378/12/10 PRIMARY CARE MEDICAL DIRECTOR v PFIZER Promotion of Champix A primary care medical director complained about the conduct of a Pfizer representative who presented at a smoking cessation

More information

Country of origin labelling for complementary healthcare products

Country of origin labelling for complementary healthcare products Country of origin labelling for complementary healthcare products A guide for business March 2018 accc.gov.au Australian Competition and Consumer Commission 23 Marcus Clarke Street, Canberra, Australian

More information

Working well with Deaf people in Social Care

Working well with Deaf people in Social Care Working well with Deaf people in Social Care As part of our ongoing work to ensure the voices of Deaf people are heard, on 13 th July 2018 we held a workshop to focus on experiences within the social care

More information

COMPLAINTS & SUGGESTIONS FORM & GUIDELINES

COMPLAINTS & SUGGESTIONS FORM & GUIDELINES COMPLAITS & SUGGESTIOS FORM & GUIDELIES Corporate Policy Title of Document Complaints & Suggestions Form & Guidelines First Issue Date This Version umber and Re-Issue Date Version 6 Signed off by Chief

More information

The Chartered Society of Physiotherapy Complaints Procedure

The Chartered Society of Physiotherapy Complaints Procedure 14 Bedford Row, London WC1R 4ED Tel +44 (0)20 7306 6666 Web www.csp.org.uk The Chartered Society of Physiotherapy Complaints Procedure issuing function Chief Executives Office date of issue May 2009 The

More information

May 6, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852

May 6, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm Rockville, MD 20852 May 6, 2016 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Submitted electronically via www.regulations.gov Re: Docket No. FDA-2014-N-1207

More information

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement

Claims about health in ads for e-cigarettes. CAP and BCAP s regulatory statement Claims about health in ads for e-cigarettes CAP and BCAP s regulatory statement Contents 1. Executive Summary... 2 2. Policy background and the decision to consult... 4 3. Decisions... 6 4. Consequence

More information

Disease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic

Disease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic Department of Rheumatology Portsmouth Hospitals NHS Trust Disease Modifying Anti-Rheumatic Medications (DMARDS) Monitoring Clinic Patient Information Leaflet Specialist Support This leaflet can be made

More information

Prepare for tobacco industry interference

Prepare for tobacco industry interference Prepare for tobacco industry interference Details and examples of the media campaigns and interference tactics used by the tobacco industry are given in the Reference Section J: OPPOSING ARGUMENTS AND

More information

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI)

Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill. Japan Tobacco International (JTI) Health (Tobacco, Nicotine etc. and Care)(Scotland) Bill Organisation name Japan Tobacco International (JTI) Japan Tobacco International (JTI) is part of the Japan Tobacco group (JT Group) of companies,

More information

Guidance for Witnesses

Guidance for Witnesses Guidance for Witnesses Introduction Giving evidence before the Fitness to Practise Committee of the General Pharmaceutical Council is likely to be unfamiliar to you and can seem to be a daunting process.

More information

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL. PHARMACEUTICAL COMMITTEE 21 October 2015 EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems and products Medicinal products authorisations, European Medicines Agency PHARM 689 PHARMACEUTICAL COMMITTEE 21 October 2015

More information

Online Services Directory

Online Services Directory informing the food industry Our Online Services Directory is: An effective and cost effective means of promoting directly to your targeted market. Highly respected and widely trusted as a leading source

More information

Recall Guidelines. for Chinese Medicine Products

Recall Guidelines. for Chinese Medicine Products Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st

More information

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS

5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Report of the Council on Ethics, Bylaws and Judicial Affairs on Advisory Opinion 5.I.1. GENERAL PRACTITIONER ANNOUNCEMENT OF CREDENTIALS IN NON-SPECIALTY INTEREST AREAS Ethical Advertising under ADA Code:

More information

The Clean Environment Commission. Public Participation in the Environmental Review Process

The Clean Environment Commission. Public Participation in the Environmental Review Process The Clean Environment Commission Public Participation in the Environmental Review Process Manitoba Clean Environment Commission Who are we? The Manitoba Clean Environment Commission is an arms-length agency

More information

Page 1 of 5 About Contact Info Feedback Site Map Help Related Subsidiary Legislation Legislative History Amendment Annotation off Search Within All Government Websites Go Home Search Browse Results My

More information

Ofcom consultation response

Ofcom consultation response Ofcom consultation response The quality of live subtitling Response by the National Deaf Children s Society (NDCS) 26 July 2013 About us The National Deaf Children s Society (NDCS) is the leading charity

More information

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedures 6 - Reporting Accreditation Decisions

Australian Sonographer Accreditation Registry (ASAR) Policy & Procedures 6 - Reporting Accreditation Decisions 1. Preamble Australian Sonographer Accreditation Registry (ASAR) ASAR s objective is to promote high standards of medical sonography in Australia which includes setting uniform, minimum standards of Sonographer

More information

HRS Group UK Drug and Alcohol Policy

HRS Group UK Drug and Alcohol Policy HRS Group UK Drug and Alcohol Policy 1.0 Introduction The HRS Group UK Policy on Alcohol and Drugs is a fundamental part of the Company s strategy to safeguard the health, safety and welfare of all its

More information

GOC Guidance for Witnesses in Fitness to Practise Committee Hearings

GOC Guidance for Witnesses in Fitness to Practise Committee Hearings GOC Guidance for Witnesses in Fitness to Practise Committee Hearings About us The GOC regulates opticians and optical businesses in the UK. There are currently around 26,000 optometrists, dispensing opticians,

More information

ACS Submission: Consultation on the advertising of electronic cigarettes

ACS Submission: Consultation on the advertising of electronic cigarettes ACS Submission: Consultation on the advertising of electronic cigarettes ACS (the Association of Convenience Stores) welcomes the opportunity to respond to Committee of Advertising Practices consultation

More information

EMPLOYEE ALCOHOL UPDATED JULY 2018 GLOBAL POLICY

EMPLOYEE ALCOHOL UPDATED JULY 2018 GLOBAL POLICY EMPLOYEE ALCOHOL UPDATED JULY 2018 GLOBAL POLICY WHO DOES THIS APPLY TO? All Diageo employees, all subsidiaries of Diageo. Joint ventures in which Diageo has a controlling interest. Third party contractors,

More information

Seal of Approval Guidelines. The Approval Program

Seal of Approval Guidelines. The Approval Program Seal of Approval Guidelines The Approval Program 1. Program Objectives 1.1 To recognise over the counter products with an Oral Health Benefit where products can be established to be safe, efficient and

More information

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer

CHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer CHE8000 Major Research Project A The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer Completed by: Lina Karlina (ID: 2067226) Lina Karlina (2067226)

More information

December 4, 2017 VIA ELECTRONIC SUBMISSION

December 4, 2017 VIA ELECTRONIC SUBMISSION VIA ELECTRONIC SUBMISSION December 4, 2017 Dockets Management Staff (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Development of a List of pre-dietary Supplement

More information

Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to

Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for the regulation of natural health products sold in Canada.

More information

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893

COUNCIL OF THE EUROPEAN UNION. Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DENLEG 51 CODEC 893 COUNCIL OF THE EUROPEAN UNION Brussels, 7 September 2009 (OR. en) 11261/09 Interinstitutional File: 2008/0002 (COD) DLEG 51 CODEC 893 LEGISLATIVE ACTS AND OTHER INSTRUMTS Subject: Common Position with

More information

Case Report ISSUES RAISED. Food and Beverage Code 2.1 (a) - Misleading / deceptive DESCRIPTION OF THE ADVERTISEMENT

Case Report ISSUES RAISED. Food and Beverage Code 2.1 (a) - Misleading / deceptive DESCRIPTION OF THE ADVERTISEMENT Case Report 1 Case Number 0128/15 2 Advertiser Nestle Australia Ltd 3 Product Food and Beverages 4 Type of Advertisement / media TV - Free to air 5 Date of Determination 15/04/2015 6 DETERMINATION Dismissed

More information

THE RESPONSIBLE PHARMACIST REGULATIONS

THE RESPONSIBLE PHARMACIST REGULATIONS THE RESPONSIBLE PHARMACIST REGULATIONS A SUMMARY OF THE RESPONSES TO PUBLIC CONSULTATION ON PROPOSALS FOR THE CONTENT OF THE REGULATIONS DH INFORMATION READER BOX Policy HR / Workforce Management Planning

More information

Accredited Registers Programme

Accredited Registers Programme Accredited Registers Programme Accreditation Panel s Decision Application for renewal from: Society of Homeopaths ( the Society ) Panel meeting: 30 January 2018 (accreditation renewed with one Condition)

More information

Organisations and/or individuals

Organisations and/or individuals 24 September 2012 EMA/HMPC/203843/2012 Committee on Herbal Medicinal Products (HMPC) Overview of comments received on Community herbal monograph on Urtica dioica L., Urtica urens L. their hybrids or their

More information

NHPD Monthly Communiqué

NHPD Monthly Communiqué NHPD Monthly Communiqué Vol. 3, Issue 5 February 2008 The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for

More information

MARKETING COMMUNICATION POLICY. Marketing Communication Policy 1

MARKETING COMMUNICATION POLICY. Marketing Communication Policy 1 MARKETING COMMUNICATION POLICY Marketing Communication Policy 1 INTRODUCTION AND PURPOSE Enjoyment in moderation is the philosophy that guides all the Carlsberg Group s marketing. As a company, we take

More information

ABAC Adjudication Panel Determination No /16

ABAC Adjudication Panel Determination No /16 ABAC Adjudication Panel Determination No. 27-29/16 Product: Pure Blonde Company: Carlton & United Breweries Media: Digital Complainant: Ms Bell & Mr Gurnett Date of decision: 1 March 2016 Panelists: Professor

More information

ANONYMOUS v PROSTRAKAN

ANONYMOUS v PROSTRAKAN CASE AUTH/2510/6/12 ANONYMOUS v PROSTRAKAN Promotion of Abstral NO BREACH OF THE CODE An anonymous physician alleged that an un-named ProStrakan representative had misled him/her with regard to the titration

More information

Scottish Parliament Region: North East Scotland. Case : Tayside NHS Board. Summary of Investigation

Scottish Parliament Region: North East Scotland. Case : Tayside NHS Board. Summary of Investigation Scottish Parliament Region: North East Scotland Case 201104213: Tayside NHS Board Summary of Investigation Category Health: General Surgical; communication Overview The complainant (Mrs C) raised concerns

More information

ABAC Adjudication Panel Determination No. 1/19

ABAC Adjudication Panel Determination No. 1/19 ABAC Adjudication Panel Determination No. 1/19 Product: Beer Company: Southern Bay Brewery Media: Digital (Twitter) Date of decision: 17 January 2019 Panelists: Professor The Hon Michael Lavarch (Chief

More information

Mental Health Trialogue Network Ireland

Mental Health Trialogue Network Ireland Mental Health Trialogue Network Ireland What is Trialogue? Trialogue is a conversation between three or more people or groups using a form of open communication known as Open Dialogue. The Trialogue uses

More information

IT and Information Acceptable Use Policy

IT and Information Acceptable Use Policy BMI IMpol04 Information Management IT and Information Acceptable Use Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive

More information

Guideline for the Sale and Supply of Practitioner Only Products

Guideline for the Sale and Supply of Practitioner Only Products Guideline for the Sale and Supply of Practitioner Only Products Edition 1, December 2011 This document provides guidance to the complementary medicine industry on the sale and supply of practitioner only

More information

Overview of comments received on European Union herbal monograph on Matricaria recutita L., flos (EMA/HMPC/55843/2011)

Overview of comments received on European Union herbal monograph on Matricaria recutita L., flos (EMA/HMPC/55843/2011) 7 July 2015 EMA/HMPC/706538/2014 Committee on Herbal Medicinal Products (HMPC) Overview of comments received on European Union herbal monograph on Matricaria recutita L., flos (EMA/HMPC/55843/2011) Table

More information

Overview of comments received on Community herbal monograph on Cucurbita pepo L, semen (EMA/HMPC/136024/2010)

Overview of comments received on Community herbal monograph on Cucurbita pepo L, semen (EMA/HMPC/136024/2010) 20 November 2012 EMA/HMPC/196724/2012 Committee on Herbal Medicinal Products (HMPC) Overview of comments received on Community herbal monograph on Cucurbita pepo L, semen (EMA/HMPC/136024/2010) Table 1:

More information

BACKGROUND + GENERAL COMMENTS

BACKGROUND + GENERAL COMMENTS Response on behalf of Sobi (Swedish Orphan Biovitrum AB) to the European Commission s Public Consultation on a Commission Notice on the Application of Articles 3, 5 and 7 of Regulation (EC) No. 141/2000

More information

A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa

A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa A proposal for collaboration between the Psychometrics Committee and the Association of Test Publishers of South Africa 27 October 2015 Table of contents Introduction... 3 Overview of the Association of

More information

What if someone complains about me? A guide to the complaint process

What if someone complains about me? A guide to the complaint process What if someone complains about me? A guide to the complaint process Introduction The purpose of the licensed building practitioner scheme is to set performance standards for building practitioners and

More information

Day care and childminding: Guidance to the National Standards

Day care and childminding: Guidance to the National Standards raising standards improving lives Day care and childminding: Guidance to the National Standards Revisions to certain criteria October 2005 Reference no: 070116 Crown copyright 2005 Reference no: 070116

More information

Professional Conduct Department User Satisfaction Survey of Complainants and Barristers. Annual Report 2010

Professional Conduct Department User Satisfaction Survey of Complainants and Barristers. Annual Report 2010 Professional Conduct Department User Satisfaction Survey of Complainants and Barristers Annual Report 2010 September 2011 Contents Introduction... 3 Methodology... 3 Response Rates... 3 Supplementary Research

More information

Case Report ISSUES RAISED. Food and Beverage Code 2.1 (a) - Misleading / deceptive DESCRIPTION OF THE ADVERTISEMENT

Case Report ISSUES RAISED. Food and Beverage Code 2.1 (a) - Misleading / deceptive DESCRIPTION OF THE ADVERTISEMENT Case Report 1 Case Number 0272/14 2 Advertiser Lion 3 Product Food and Beverages 4 Type of Advertisement / media Free TV 5 Date of Determination 13/08/2014 6 DETERMINATION Dismissed ISSUES RAISED Food

More information

Permitted Indications Determination

Permitted Indications Determination Complementary Medicines Australia submission: Permitted Indications Determination Submission (1) of a multi-part submission: Health maintenance claims regarding cholesterol, triglycerides, blood sugar

More information

LEAF Marque Assurance Programme

LEAF Marque Assurance Programme Invisible ISEAL Code It is important that the integrity of the LEAF Marque Standard is upheld therefore the LEAF Marque Standards System has an Assurance Programme to ensure this. This document outlines

More information

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use 25 October 1999 EMEA/HMPWP/23/99 EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS UPDATED DRAFT POINTS

More information

National curriculum tests maladministration procedures. March 2007 QCA/07/3097

National curriculum tests maladministration procedures. March 2007 QCA/07/3097 National curriculum tests maladministration procedures March 2007 QCA/07/3097 Contents 1. Purpose of document... 3 2. Scope... 4 3. General principles of national curriculum tests maladministration investigations...

More information

Ankle arthroscopy. If you have any further questions, please speak to a doctor or nurse caring for you

Ankle arthroscopy. If you have any further questions, please speak to a doctor or nurse caring for you Ankle arthroscopy This leaflet aims to answer your questions about having an ankle arthroscopy. It explains the benefits, risks and alternatives, as well as what you can expect when you come to hospital.

More information

things that matter most.

things that matter most. ANIMALS & ALOE VERA Who are we? Founded in 1978, Forever Living Products has led the way for the world to rediscover the benefits of aloe vera. With annual worldwide sales in excess of $2.6 billion, we

More information

Does the Metropolitan Police Service, and/or any other security service, have the legal right to conduct themselves in a prejudicial manner?

Does the Metropolitan Police Service, and/or any other security service, have the legal right to conduct themselves in a prejudicial manner? Freedom of Information Request Reference No: I note you seek access to the following information: Does the Metropolitan Police Service, and/or any other security service, have the legal right to conduct

More information

- Conduct effective follow up visits when missing children return home ensuring intelligence is shared with appropriate partners.

- Conduct effective follow up visits when missing children return home ensuring intelligence is shared with appropriate partners. Job title: Grade: Role code: Status: Main responsibilities: Missing and Child Exploitation PCSO Grade D SDV027 Police Staff Main purpose of the role: Conduct enquiries to locate missing children as directed

More information

EPF s response to the European Commission s public consultation on the "Summary of Clinical Trial Results for Laypersons"

EPF s response to the European Commission s public consultation on the Summary of Clinical Trial Results for Laypersons EPF s response to the European Commission s public consultation on the "Summary of Clinical Trial Results for Laypersons" August 2016 This document received funding under an operating grant from the European

More information

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business

Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses

More information

Representing the Up Baby Project CIC

Representing the Up Baby Project CIC Representing the Up Baby Project CIC REPRESENTING UP FEBRUARY 2016 1 Introduction We would like to thank you for considering representing The Up Project at an upcoming event. Without your help we would

More information

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes

Texas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes Texas Bill to Regulate Vapor Products Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes or vapor, have been trending all over the state of Texas as a tobacco alternative,

More information

Unproven treatments and motor neurone disease

Unproven treatments and motor neurone disease C Unproven treatments and motor neurone disease This information sheet presents the facts about alternative or unproven treatments. It aims to provide people with the information they need in order to

More information

Scottish Parliament Region: Lothian. Case : A Dentist, Lothian NHS Board. Summary of Investigation. Category Health: Dental

Scottish Parliament Region: Lothian. Case : A Dentist, Lothian NHS Board. Summary of Investigation. Category Health: Dental Scottish Parliament Region: Lothian Case 200600710: A Dentist, Lothian NHS Board Summary of Investigation Category Health: Dental Overview The complainant (Mr C) raised a number of concerns about the treatment

More information

Importing pre-packaged foods

Importing pre-packaged foods Importing pre-packaged foods Information for those who wish to import pre-packa Starting your business This brochure provides important information for those who wish to import and sell pre-packaged foods

More information

Alcohol (Minimum Pricing) (Scotland) Bill. WM Morrison Supermarkets. 1.1 Morrisons has 56 stores and employs over 14,000 people in Scotland.

Alcohol (Minimum Pricing) (Scotland) Bill. WM Morrison Supermarkets. 1.1 Morrisons has 56 stores and employs over 14,000 people in Scotland. Alcohol (Minimum Pricing) (Scotland) Bill WM Morrison Supermarkets 1. Introduction 1.1 Morrisons has 56 stores and employs over 14,000 people in Scotland. 1.2 Morrisons welcomes the opportunity to respond

More information

GUIDANCE TO CLUBS NEW CLUB AFFILIATION FEES AND PROCEDURES

GUIDANCE TO CLUBS NEW CLUB AFFILIATION FEES AND PROCEDURES GUIDANCE TO CLUBS NEW CLUB AFFILIATION FEES AND PROCEDURES New affiliation fee from 1 April 2018 From 1 April 2018, all clubs will be charged the same annual affiliation fee, which the Board of Directors

More information

October To Get Brown Tanning Trade/Wholesale Customers:

October To Get Brown Tanning Trade/Wholesale Customers: October 2011 To Get Brown Tanning Trade/Wholesale Customers: As a sunbed operator you will be aware of the controversy surrounding our industry, and you may have received communications from the Commerce

More information

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion

Re: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

CNHC Guidance on The Cancer Act (Please note this does not constitute legal advice)

CNHC Guidance on The Cancer Act (Please note this does not constitute legal advice) CNHC Guidance on The Cancer Act 1939 (Please note this does not constitute legal advice) 1. Introduction 1.1. In November 2012 CNHC produced Advertising Guidance to support CNHC registered practitioners

More information

Professional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines

Professional Development: proposals for assuring the continuing fitness to practise of osteopaths. draft Peer Discussion Review Guidelines 5 Continuing Professional Development: proposals for assuring the continuing fitness to practise of osteopaths draft Peer Discussion Review Guidelines February January 2015 2 draft Peer Discussion Review

More information

MS Society Safeguarding Adults Policy and Procedure (Scotland)

MS Society Safeguarding Adults Policy and Procedure (Scotland) MS Society Safeguarding Adults Policy and Procedure (Scotland) Safeguarding Adults Policy The phrase adult support and protection is used instead of safeguarding in Scotland. However for consistency across

More information

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011. CHAPTER I Scope and definitions. Article 1 Scope.

More information

ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held May 11, 2010

ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held May 11, 2010 ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held May 11, 2010 Wyeth Consumer Healthcare Pty Limited ( Wyeth ) v. Bayer Australia Limited ( Bayer ) Citracal promotional claims. 1. Wyeth complains

More information

Lesson 8 Using Medicines in Safe Ways

Lesson 8 Using Medicines in Safe Ways Lesson 8 Using Medicines in Safe Ways Overview Students identify symptoms or signals the body sends when a person is sick. They define medicine and learn the difference between prescription and over-the-counter

More information

Safeguarding Children and Young People Policy

Safeguarding Children and Young People Policy Safeguarding Children and Young People Policy Policy Summary This policy outlines our commitment to keeping the children and young people who engage with the Red Cross safe. It outlines the expectations

More information